Stock listing

OTC:PBIO Pressure BioSciences, Inc. Stock

Follow Pressure BioSciences, Inc. into a list and get an email when it puts out news.

Share price · OTC:PBIO

$0.0002 USD 0.0000 (0.0%)

Close on Nov 20, 2026

Past year -66.7% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$0.0002 – $0.0002 USDNov 20, 2026
Volume
8,006 sharesNov 20, 2026
Market cap
$8,193 USDAt the close on Nov 20, 2026 · price × 40.97M shares outstanding
52-week range
$0.0001 – $0.2000 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$1 USDMedian day 0 shares · 42 days with no trades · last 3 months, Aug 20, 2026 – Nov 20, 2026
Pressure BioSciences, Inc. logo

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · OTC:PBIO · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$0.00020.00000.0%$0.0002$0.0002$0.00028,006
$0.00020.00000.0%$0.0002$0.0002$0.00021,947
$0.00020.00000.0%$0.0002$0.0002$0.00026,091
$0.00020.00000.0%$0.0005$0.0005$0.000210,845
$0.00020.00000.0%$0.0002$0.0002$0.00022,627
$0.00020.00000.0%$0.0002$0.0002$0.000281,092
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.0002-0.0003-60.0%$0.0002$0.0002$0.000225,927
$0.00050.00000.0%$0.0005$0.0005$0.00050
$0.00050.00000.0%$0.0005$0.0005$0.00050
$0.00050.00000.0%$0.0005$0.0005$0.00050
$0.00050.00000.0%$0.0005$0.0005$0.0005334
$0.00050.00000.0%$0.0005$0.0005$0.00050
$0.00050.00000.0%$0.0005$0.0005$0.00050
$0.00050.00000.0%$0.0005$0.0005$0.00050
$0.00050.00000.0%$0.0005$0.0005$0.00050
$0.00050.00000.0%$0.0005$0.0005$0.00050
$0.00050.00000.0%$0.0005$0.0005$0.00050
$0.00050.00000.0%$0.0005$0.0005$0.00050
$0.00050.00000.0%$0.0005$0.0005$0.00050
$0.00050.00000.0%$0.0005$0.0005$0.00050
$0.00050.00000.0%$0.0002$0.0005$0.0002700
$0.00050.00000.0%$0.0005$0.0005$0.00051,000
$0.0005+0.0003+150.0%$0.0005$0.0005$0.0005107,000
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.000225,800
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0001$0.0002$0.00017,600
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.0002+0.0001+100.0%$0.0002$0.0002$0.0002500
$0.00010.00000.0%$0.0001$0.0001$0.0001800
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.0001-0.0003-75.0%$0.0001$0.0001$0.000120,000
$0.00040.00000.0%$0.0004$0.0004$0.00040
$0.00040.00000.0%$0.0398$0.0398$0.0004800
$0.00040.00000.0%$0.0004$0.0004$0.00040
$0.00040.00000.0%$0.0004$0.0004$0.0004335
$0.00040.00000.0%$0.0004$0.0004$0.00040
$0.00040.00000.0%$0.0004$0.0004$0.00040
$0.00040.00000.0%$0.0004$0.0004$0.00040
$0.00040.00000.0%$0.0004$0.0004$0.00040
$0.00040.00000.0%$0.0004$0.0004$0.00040
$0.00040.00000.0%$0.0004$0.0004$0.00040
$0.00040.00000.0%$0.0004$0.0004$0.00040
$0.00040.00000.0%$0.0004$0.0004$0.00040
$0.00040.00000.0%$0.0004$0.0004$0.00040
$0.00040.00000.0%$0.0004$0.0004$0.0004187

Splits

1 split · OTC:PBIO · every price before a split is adjusted for it

DayRatioWhat
1-for-30Consolidation
Ticker
OTC:PBIO
Asset type
Stock
Exchange
OTC
Currency
USD

Pressure BioSciences, Inc. on 6ix

Calls
11 calls with a replay · 11 with a transcript · latest Nov 21, 2023
Decks
19 decks · latest May 2023

Valuation

price Nov 20, 2026

Enterprise value
No statements on 6ix yet
P/E
No statements on 6ix yet
EV/sales
No statements on 6ix yet
EV/EBITDA
No statements on 6ix yet
Price/book
No statements on 6ix yet
Gross margin
No statements on 6ix yet
Operating margin
No statements on 6ix yet
Net margin
No statements on 6ix yet
Debt to equity
No statements on 6ix yet
Beta vs S&P 500
0.52

Team and board

Officers

OfficerRole
Richard T. SchumacherPresident, Chief Executive Officer and Director
Edmund TingSenior Vice President of Engineering
Alexander LazarevChief Science Officer

Board

DirectorRole
Jeffrey N. PetersonChairman of the Board
Michael S. UrdeaDirector
Richard T. SchumacherPresident, Chief Executive Officer and Director

Events

Results days

QuarterResultsShare move
Quarter to Mar 31, 2026May 21, 20260.0%
Quarter to Dec 31, 2025Feb 25, 20260.0%
Quarter to Sep 30, 2025Nov 28, 2025−50.0%
Quarter to Jun 30, 2025Aug 29, 20250.0%
Quarter to Mar 31, 2025May 30, 20250.0%
Quarter to Dec 31, 2024Feb 7, 2025+100.0%
Quarter to Sep 30, 2024Dec 16, 2024+108.3%
Q2 2024Aug 15, 20240.0%
Q1 2024Jun 7, 2024 · After close−7.7%
Q3 2023Nov 20, 2023 · After close−8.0%
All 19 quarters
QuarterResultsShare move
Q2 2023Aug 22, 2023 · After close+0.3%
Q1 2023May 16, 2023 · After close−1.0%
Q3 2022Nov 22, 2022 · After close0.0%
Q2 2022Aug 18, 2022+3.0%
Q1 2022Apr 5, 2022−6.8%
Q3 2021Nov 17, 2021−2.4%
Q2 2021Aug 19, 2021−5.8%
Q1 2021Apr 21, 2021+4.0%
Q4 2020Mar 31, 2021+2.4%

Open Events

Decks

DeckKindSlidesDate
Investor Presentation (May 2023)Investor deck25 slidesMay 2023
Investor Presentation (August 2021)Investor deck7 slidesAug 20, 2021
Investor Presentation (March 2017)Investor deck21 slidesMarch 2017
Investor Presentation (August 2016)Investor deck24 slidesAugust 2016
SeeThruEquity Winter Microcap Investor Conference (February 2015)Conference19 slidesFeb 11, 2015
FSXinterlinked Investor Conference 2014Conference16 slidesOct 31, 2014
Rodman and Renshaw Global Investment Conference 2014Conference22 slidesSep 16, 2014
WallStreet Research (August 2014)Conference26 slidesAug 25, 2014
Investor Presentation (July 2014)Investor deck25 slidesJul 15, 2014
Investor Presentation (December 2013)Investor deck28 slidesDec 12, 2013
All 19 decks
DeckKindSlidesDate
SeeThruEquity NYC (November 2013)Conference25 slidesNov 18, 2013
Investor Presentation (March 2012)Investor deck27 slidesMar 14, 2012
BioPharm America 2010Conference20 slidesSep 16, 2010
Technical Presentation (June 2010)Technical10 slidesJune 2010
Technical Presentation (May 2010)Technical49 slidesMay 21, 2010
Technical Presentation (April 2010)Technical35 slidesApril 2010
Technical Presentation (April 2010)Technical43 slidesApril 2010
Technical Presentation (December 2009)Technical35 slidesDecember 2009
Plant and Animal Genome XVI Conference 2008Conference30 slidesJan 15, 2008

Open Decks

Financials

Annual, in USD

Income statement

LineFY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015FY2014
Revenue1.98M1.73M2.00M1.22M1.81M2.46M2.24M1.98M1.80M1.37M
Cost of revenue1.18M2.01M942.4K582.9K1.20M1.28M1.27M834.0K1.71M586.0K
Gross profit799.6K-284.7K1.06M637.7K612.9K1.18M967.1K1.14M83.3K1.37M
Research and development1.37M969.5K1.10M1.14M1.16M1.21M988.6K1.18M1.10M952.6K
Selling, general and administrative8.94M3.64M4.14M4.08M5.26M4.45M4.63M3.70M3.65M3.11M
Operating income-9.50M-4.90M-4.19M-4.59M-5.81M-4.48M-4.65M-3.74M-3.57M-3.34M
Depreciation and amortization112.5K119.8K110.1K5.56M1.48M1.61M8.58K17.9K25.3K1.38M
EBITDA-9.39M-4.78M-4.08M978.4K-4.33M-2.87M-4.64M-3.72M-3.54M-1.96M
Interest expense15.6M10.4M14.5M8.34M5.28M4.17M0000
Income before tax-29.3M-16.1M-20.2M-16.0M-11.9M-9.70M-10.7M-2.71M-7.42M-4.61M
Income tax-217.2K00000
Net income-29.3M-16.1M-20.2M-16.0M-11.7M-9.70M-10.7M-2.71M-7.42M-4.61M
Earnings per share, basic-0.83-1.17-2.21-3.84-4.57-5.76-7.98-0.09-0.25

Balance sheet

LineFY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015FY2014
Cash and equivalents81.3K3.87K132.3K18.5K29.6K103.1K81.0K138.4K116.8K473.9K
Receivables151.2K295.4K154.7K131.2K229.4K474.8K206.8K281.3K113.3K272.0K
Inventory304.9K686.4K1.15M592.8K617.7K765.5K857.7K905.3K1.04M850.6K
Current assets760.1K1.24M1.86M1.06M1.09M1.51M1.37M1.59M1.49M1.71M
Property, plant and equipment511.4K16.5K132.2K205.7K22.7K9.41K20.1K36.0K
Total assets1.05M2.01M2.83M2.30M1.82M2.40M2.16M1.63M1.80M1.74M
Accounts payable1.32M637.2K527.9K3.23M815.8K658.9K589.3K407.2K941.4K1.91M
Current liabilities33.6M34.4M24.6M18.5M13.9M8.35M16.7M9.27M9.57M3.77M
Long-term debt161.9K150.0K150.0K527.0K136.4K655.3K177.3K
Total liabilities33.8M34.7M25.0M19.2M13.9M8.52M16.8M10.0M9.78M3.80M
Shareholders' equity-32.8M-32.7M-22.2M-16.9M-12.1M-6.13M-14.6M-8.38M-7.98M-2.06M
Shares outstanding35.4M13.7M9.12M4.17M2.55M1.68M1.34M31.0M18.7M

Cash flow

LineFY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015FY2014
Cash from operations-3.19M-4.48M-4.87M-4.88M-6.33M-5.70M-3.90M-3.81M-3.82M-3.21M
Capital spending-7.50K-20.8K-122.9K-1.66K-23.4K-23.4K-21.8K-7.20K-9.41K-7.14K
Free cash flow-3.19M-4.50M-4.99M-4.88M-6.35M-5.70M-4.08M-3.81M-3.83M-3.22M
Cash from investing-122.9K-796.7K-23.4K-23.4K-171.8K-7.20K-9.41K-7.14K
Cash from financing3.27M4.37M5.11M5.67M6.28M5.72M4.02M3.83M3.47M3.66M
Share buybacks150.0K3.28M2.82M140.2K294.7K294.7K2.09M
Change in cash77.4K-128.4K113.8K-11.1K-73.5K22.1K-57.3K21.6K-357.2K442.5K

Open Financials

Cap table

Built by 6ix from Pressure BioSciences, Inc.’s releases

Common shares
40,967,084
Fully diluted
40,967,084

Fully diluted

LineShares
Common shares40,967,084

Share count over time

CountShares
Nov 22, 202640,967,084

Open Cap table

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Kevin Pollack
Other companies: Taronis Fuels Inc (Director · Mar 30, 2020 – Jan 7, 2021 · Past); Taronis Technologies Inc (Director · Apr 1, 2019 – Nov 21, 2019 · Past); Opiant Pharmaceuticals Inc (See Remarks, Director · Apr 17, 2012 – Jan 13, 2017 · Past)
Director · Jul 3, 2012 – Mar 27, 2024 · Past
Conrad F Mir
Other companies: Calmare Therapeutics Inc (President & CEO, Director · Feb 12, 2018 – Feb 12, 2018 · Past)
CFO · Nov 28, 2012 – Nov 28, 2012 · Past
J Donald Payne
Other companies: Advanced Environmental Petroleum Producers Inc (Secretary, Director · Apr 6, 2017 – Sep 26, 2017 · Past)
Director · Mar 1, 2006 – Nov 7, 2011 · Past
Joseph Luis Damasio Jr
Other companies: Harvard Apparatus Regenerative Technology Inc (Chief Financial Officer · Aug 8, 2022 – Aug 8, 2022 · Past)
VP of FINANCE and CFO · Dec 20, 2011 – Dec 19, 2018 · Past
Alexander LazarevChief Science Officer · Since at least Nov 5, 2026
Edmund TingSenior Vice President of Engineering · Since at least Mar 30, 2010
Jeffrey N. PetersonChairman of the Board · Since at least Nov 5, 2026
Michael S. UrdeaDirector · Since at least Apr 29, 2022
Richard ThomleyChief Financial Officer · Sep 27, 2013 – Dec 22, 2014 · Past
Richard T. SchumacherPresident, Chief Executive Officer and Director · Since at least Mar 30, 2006
All 11 people
PersonSeat
R Wayne FritzscheDirector · Apr 15, 2008 – Aug 15, 2012 · Past

Open People

Log in to ask 6ix AI your own questions about Pressure BioSciences, Inc.